Global Human Growth Hormone Market || SWOT, Industry Analysis (2021-2031) & Opportunity Assessment | Novo Nordisk, Eli, Lilly and company, Merck & Co. Inc

Human growth hormone, also known as somatotropin or growth hormone, helps in the growth of all the essential tissues of the body including bones. It is one of the most essential hormones required by a human body. Human growth hormone is produced and secreted by somatotrophs, anterior pituitary cells that secrete almost 1-2 milligrams of hormones every day. Synthetic human growth hormone was developed in the 1980s and was approved by FDA for use in children and adults. As per a study conducted by the Partnership Attitude Tracking Study (PATS), the usage of synthetic human growth hormone by teenagers has witnessed an increase of 120% from 2012 to 2013.

Human growth hormone spurs muscle strength, growth, and exercise performance. Lower levels of human growth hormone can increase the risk of diseases, hamper quality of life and initiate fat gain. Human growth hormone helps avoid several disorders, which include growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, Noonan syndrome, SHOX gene haploinsufficiency, idiopathic short stature, Creutzfeldt-Jakob disease, and chronic kidney diseases.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1389

Human Growth Hormone (HGH) Market: Drivers

Long-acting human growth hormone formulations are consistently developing. Increase in the prevalence of human growth hormone deficiency, HIV/AIDS, cancer, Turner syndrome, SHOX gene haploinsufficiency, skeletal dysplasia, as well as increase in healthcare expenditure and the availability of advanced recombinant DNA technology are among factors expected to drive the human growth hormone market over the forecast period.

However, costs of the R&D required for human growth hormone are extremely high. The high cost of treatment is another factor restraining the growth of the human growth hormone market. Adverse effects of recombinant human growth hormones, which include joint & muscle pain, swelling in the legs & arms, increased insulin resistance, and carpal tunnel syndrome, are also expected to hamper the growth of the human growth hormone market over the forecast period.

Human Growth Hormone (HGH) Market: Segmentation

The global Human Growth Hormone (HGH) market can be segmented on the basis of application type, end users, and geography.

Based on application type, the global Human Growth Hormone (HGH) market is segmented as:

• Growth hormone deficiency
• Idiopathic short stature
• Turner syndrome
• Small for gestational age
• Prader-Willi syndrome
• Others

To receive extensive list of important regions, ask for TOC here – https://www.factmr.com/connectus/sample?flag=T&rep_id=1389

Based on end users, the global Human Growth Hormone (HGH) market is segmented as:

• Hospitals
• Clinics

Based on geography, the global Human Growth Hormone (HGH) market is segmented as:

• North America
• Latin America
• Europe
• CIS & Russia
• Japan
• APEJ
• Middle East & Africa

Pre-Book Right Now for Exclusive Analyst Support – https://www.factmr.com/checkout/1389/S

Human Growth Hormone (HGH) Market: Key Players

Some of the major market participants operating in the global Human Growth Hormone (HGH) market are Novo Nordisk, Eli, Lilly and company, Merck & Co. Inc.; Pfizer Inc., Genentech, Inc.; Ferring Holding SA; Sandoz International GmbH; and Ipsen.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com